Inder S. Anand

Sustained Reduction of Aldosterone in Response to the Angiotensin Receptor Blocker Valsartan in Patients With Chronic Heart Failure: Results From the Valsartan Heart Failure Trial

J. Cohn, R. Latini, S. Masson, 2003, Circulation.

Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).

Gianni Tognoni, Simona Barlera, J. Cohn, 2008, Journal of the American College of Cardiology.